コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 = 0.037 for systolic pressure; P = 0.019 for diastolic pressure).
2 ant change in heart rate or left ventricular diastolic pressure.
3 lobal longitudinal strain (LVGLS) and LV end-diastolic pressure.
4 ge occurrence of a sympathetic burst against diastolic pressure.
5 ction, and an increased left ventricular end-diastolic pressure.
6 peak pressure and a dramatic increase in end diastolic pressure.
7 ystolic pressure conferred greater risk than diastolic pressure.
8 ure and -0.2 (95% CI: -4.1, 3.7) mmHg/kg for diastolic pressure.
9 more rapid increase in left ventricular end-diastolic pressure.
10 Relationships were smaller for diastolic pressure.
11 dge pressure (PCWP) and left ventricular end-diastolic pressure.
12 s include LA dP/dt, LA relaxation and LV end-diastolic pressure.
13 kg/m2 for body mass index, and 0.48 mmHg for diastolic pressure.
14 the cuff technique in predicting the aortic diastolic pressure.
15 e systolic pressure without greatly reducing diastolic pressure.
16 intracellular calcium, but did not decrease diastolic pressure.
17 left ventricular developed pressure and end diastolic pressure.
18 fibrosis, and decreased left ventricular end-diastolic pressure.
19 reduced rate pressure product and increased diastolic pressure.
20 nd maximum LV dP/dt, as well as lower LV end-diastolic pressure.
21 mean arterial pressure than for systolic or diastolic pressure.
22 tion at rest and on exercise, and higher end-diastolic pressures.
23 r estimates of pulmonary artery systolic and diastolic pressures.
24 of pulse pressure above that of systolic and diastolic pressures.
25 ic LV diameter was smaller at matched LV end-diastolic pressures.
26 sure, -0.7 mm Hg (CI, -0.6 to -0.9 mm Hg) in diastolic pressure, -0.17 mmol/L (CI, -0.09 to -0.25 mmo
27 . 28+/-10 mmHg, P<0.001), and lowered LV end diastolic pressure (10+/-1 vs. 86+/-13 mmHg, P<0.001) fo
28 y artery pressure (25+/-10 mm Hg) and LV end-diastolic pressure (11+/-5 mm Hg; P<0.001 for both compa
29 RV dysfunction was indicated by elevated end-diastolic pressure (11.3+/-2.5 versus 5.7+/-2.0 mm Hg; P
30 ss (70 +/- 2 vs. 63 +/- 1%), enhanced LV end-diastolic pressure (14 +/- 2 vs. 8 +/- 1 mmHg) and these
31 -80 versus 165+/-71 mL, P<0.0001) and LV end-diastolic pressure (14.3+/-10.2 versus 9.9+/-9.3 mm Hg,
32 8+/-5 mm Hg, P=0.04), lower pulmonary artery diastolic pressures (14+/-9 versus 21+/-9 mm Hg, P=0.01)
33 an pressure, 39+/-12 mm Hg), elevated LV end-diastolic pressure (19+/-5 mm Hg), and reduced stroke vo
34 P-induced cardiac function (left ventricular diastolic pressure, 20 +/- 5.9%; +/- dP/dt, 5.2 +/- 4.5%
35 ents revealed similar reductions in systolic/diastolic pressure (-22/12 versus -21/13 mm Hg) and LV m
36 diastolic function (eg, left ventricular end-diastolic pressure 23+/-9 in WT and 51+/-5 mm Hg in GAMT
37 ities, including higher left ventricular end-diastolic pressures (24.3+/-4.6 versus 12.9+/-5.5 mm Hg)
38 n reduced cardiac function (left ventricular diastolic pressure, 39 +/- 3.8%; +/- dP/dt, 32 +/- 4.4%,
39 artery conduit group having a higher aortic diastolic pressure (55 versus 42 mm Hg), a narrowed syst
40 NTg (53 versus 38%, P<0.01), whereas LV end-diastolic pressure (6 versus 12 mm Hg, P<0.05) and lung
42 patients with elevated left ventricular end-diastolic pressure, a finding largely attributed to the
44 he combination of a high systolic and normal diastolic pressure-a widened pulse pressure-seems to be
45 gridAND correlated with left ventricular end-diastolic pressure across both groups (average R(2) = 0.
47 s >35% had an increased left ventricular end-diastolic pressure and a marked increase in heart weight
48 y artery pressure, high left ventricular end-diastolic pressure and a normal ejection fraction, some
53 fractional shortening, and increased LV end-diastolic pressure and fibrosis (P<0.05 versus control w
57 evidenced by increased left ventricular end-diastolic pressure and left ventricular volume indexes.
59 ed HF, CXL-1020 reduced left ventricular end-diastolic pressure and myocardial oxygen consumption whi
61 <.01 for difference between pulmonary artery diastolic pressure and pulmonary artery occlusion pressu
62 son, the regression between pulmonary artery diastolic pressure and pulmonary artery occlusion pressu
63 Improvement in postischemic recovery of end-diastolic pressure and reduction in infarct size was obs
64 beat-to-beat changes in left ventricular end-diastolic pressure and SV was used as an index of the dy
65 output and decreases in left ventricular end-diastolic pressure and systemic vascular resistance.
66 offset the pacing-induced increase in LV end-diastolic pressure and the time constant of isovolumic r
69 oconstriction from ET-1 led to higher aortic diastolic pressure and very narrow pulse pressure after
70 ding heart rate, peak-systolic pressure, end-diastolic pressure and volume, end-systolic pressure and
71 myocardium, as demonstrated by elevated end-diastolic pressures and decreased percent recovery of de
73 ts, the pathophysiological cause of elevated diastolic pressures and heart failure is abnormal diasto
74 n Fontan, manifested by high ventricular end-diastolic pressures and pulmonary arterial wedge pressur
77 , its association with increasing left heart diastolic pressures and systemic vascular stiffening, an
78 tolic pressure, 1.27 (95% CI, 1.01-1.60) for diastolic pressure, and 1.30 (95% CI, 1.05-1.61) for mea
79 e increase at 40 mm Hg, left ventricular end-diastolic pressure, and cardiac index, was significantly
80 de, left ventricular developed pressure, end-diastolic pressure, and coronary flow were significantly
81 aturation, elevated systemic ventricular end-diastolic pressure, and elevated main pulmonary artery p
82 lated with PH severity, left ventricular end-diastolic pressure, and left ventricular dilatation.
83 , mean arterial pressure, systolic pressure, diastolic pressure, and left ventricular systolic pressu
84 inephrine levels, lower left ventricular end-diastolic pressure, and lower right ventricle/body weigh
86 vels, baseline and in-treatment systolic and diastolic pressures, and for diuretic therapy, losartan-
87 ed LV mass, posterior wall thickness and end diastolic pressures, and increased fractional shortening
88 d albuminuria, similar baseline systolic and diastolic pressures, and reductions in diastolic pressur
90 At similar left ventricular volumes, their diastolic pressures are more than twice as high as in co
94 sure from randomization showed a benefit for diastolic pressure at month 12 (P = 0.039) but not at mo
96 a function of elevated left ventricular end diastolic pressure but was associated with increased per
98 e (75 to 100 mmol/d) will, on average, lower diastolic pressure by approximately 1 mmHg and systolic
99 n resistance (homeostasis model assessment), diastolic pressure, C-reactive protein, and the number o
100 ng diastole; hence, an excessive decrease in diastolic pressure can significantly hamper perfusion.
101 trolled delivery group (left ventricular end-diastolic pressure, cardiac index, +dP/dt, -dP/dt, and t
103 nt parameters, including RV systolic and end-diastolic pressures, cardiac output, RV size, and morbid
110 r time constant of isovolumic relaxation and diastolic pressure (Delta +29+/-9% and +38+/-12%) and a
111 CPA produced improvement in postischemic end-diastolic pressure, developed pressure, and rate-pressur
113 ed (n=49) subgroups according to whether the diastolic pressure difference (diastolic pulmonary arter
115 trol for 15 variables plus proline, systolic/diastolic pressure differences were -2.7/-2.0 mm Hg (z s
116 emic O(2) delivery, and (4) elevated cardiac diastolic pressures do not represent systolic dysfunctio
117 ive ethnic differences in either systolic or diastolic pressure during childhood and adolescence.
119 velop increases in left ventricular (LV) end-diastolic pressures during exercise that contribute to d
120 astolic volume (EDV) and Doppler-derived end-diastolic pressure (EDP) were used to derive the diastol
121 t ventricular developed pressure (LVDP), end diastolic pressure (EDP), and ATP were measured througho
122 q, even with marked reduction of volume (end-diastolic pressure [EDP], 1 to 2 mm Hg), whereas in cont
123 -derived baseline estimated pulmonary artery diastolic pressure (ePAD) and change from baseline ePAD
124 +/-10 mm, estimated resting pulmonary artery diastolic pressure (ePAD) of 16+/-9 mm Hg, and diastolic
127 ion coefficient between the pulmonary artery diastolic pressure estimate of pulmonary artery occlusio
128 contrast, the bias for the pulmonary artery diastolic pressure estimate significantly increased with
130 stolic pressure declined in both groups, but diastolic pressure fell less with ALT-711 (P=0.056).
131 dP/dt max, -dP/dt min, and left ventricular diastolic pressure followed injection of MSCs before ind
132 index, LV dP/dt40, LV negative dP/dt, and LV diastolic pressure followed injection of MSCs, regardles
133 d protocol based on the left ventricular end-diastolic pressure for the prevention of contrast-induce
134 unloading manifested by a decrease in LV end-diastolic pressure from 11.4 +/- 9.0 mm Hg to 8.8 +/- 5.
136 ng systolic blood pressure > 140 mmHg and/or diastolic pressure > 90 mmHg; incident hypertension used
137 tension (systolic pressure > or =140 mmHg or diastolic pressure > or = 90 mmHg) across quintiles of B
138 a systolic blood pressure > or =140 mm Hg or diastolic pressure > or =90 mm Hg at any FHS cycle exami
139 IV) more than doubled chamber stiffness (end-diastolic pressure >25 mm Hg, P<0.001), whereas stiffnes
140 ure into postcapillary (left ventricular end-diastolic pressure, >15 mm Hg; n=269) and precapillary g
142 ntly in patients in the left ventricular end-diastolic pressure-guided group (6.7% [12/178]) than in
143 cated in a 1:1 ratio to left ventricular end-diastolic pressure-guided volume expansion (n=196) or th
144 Interventions were performed after LV end-diastolic pressure had increased approximately 7 mm Hg.
145 pressure, without associated changes in end-diastolic pressure, had no significant effect on vascula
146 re (PP), the difference between systolic and diastolic pressure, has been associated with cardiovascu
147 demonstrated significant increases in LV end-diastolic pressure, heart and body weight, and LV chambe
148 ut (57%) and significant decreases in LV end-diastolic pressure, heart rate, and systemic vascular re
149 n, in-treatment use of digoxin, systolic and diastolic pressure, heart rate, QRS duration, Cornell vo
152 =0.02) and more likely to have higher RV end-diastolic pressure (HR, 1.07; 95% CI, 1.00-1.15; P=0.057
153 n of I79N hearts significantly worsened (end-diastolic pressure: I79N 20 +/- 4 mmHg versus CON 13 +/-
157 all subjects with a significant reduction in diastolic pressure in the HYL group (P = 0.008) but not
161 further dichotomized by left ventricular end-diastolic pressure into postcapillary (left ventricular
162 N(+)HFpEF had increased left ventricular end-diastolic pressure, left atrial volume, N-terminal prope
163 pertension (systolic pressure 160-200 mm Hg; diastolic pressure <110 mm Hg) who were aged 80 years or
165 fraction) and hemodynamic variables (LV end-diastolic pressure, LV dP/dtmax, preload adjusted maxima
166 of a noninvasive measure of left ventricular diastolic pressure (LVDP) early after acute myocardial i
167 paradoxically decreased left ventricular end-diastolic pressure (LVEDP) and left ventricular end-dias
168 t led to an increase of left ventricular end-diastolic pressure (LVEDP) by > or =20 mm Hg (ie, cardia
169 astolic volumes with little effect on LV end-diastolic pressure (LVEDP) or the end-diastolic P-V rela
170 lood pressure (DBP) and left ventricular end-diastolic pressure (LVEDP) to systolic blood pressure (S
171 ary enalaprilat reduced left ventricular end-diastolic pressure (LVEDP), but not left ventricular end
172 asurements, including cardiac output, LV end-diastolic pressure (LVEDP), rate of pressure rise at LV
173 onal marker of elevated left ventricular end-diastolic pressure (LVEDP), which adds prognostic value
174 In healthy and CHF (left ventricular end diastolic pressure (LVEDP): 6 +/- 1 versus 14 +/- 1 mmHg
175 creased DCS (isovolumic left ventricular end-diastolic pressure [LVEDP] increased 10 mm Hg, P<0.001,
176 omanometer-tipped catheters, and the mean LV diastolic pressure (M-LVDP) was used as a surrogate for
177 es, SMV activation increased the mean aortic diastolic pressure (MADP) by 26.5+/-3.5%, the mean diast
180 ore defibrillation: 1) right atrial systolic/diastolic pressures (mm Hg) were lower (85 +/- 19, 4 +/-
181 stolic and diastolic function, higher LV end-diastolic pressure, more cardiomyocyte hypertrophy, and
182 )HFpEF had no change in left ventricular end-diastolic pressure, myocardial passive stiffness, collag
184 early rapid filling and equalization of end-diastolic pressures obtained by cardiac catheterization
185 n, cardiac systolic pressure generation at a diastolic pressure of 15 mm Hg averaged 110 +/- 11, 66 +
186 end-diastolic volume at an idealized LV end-diastolic pressure of 20 mm Hg (EDV20), and RV remodelin
188 systolic pressure of 139 mm Hg or lower and diastolic pressure of 85 to 89 mm Hg, were randomly assi
189 of systolic pressure of 130 to 139 mm Hg and diastolic pressure of 89 mm Hg or lower, or systolic pre
191 pedance threshold valve results in sustained diastolic pressures of >55 mm Hg in patients in cardiac
192 r systolic pressures of 110 to 130 mm Hg and diastolic pressures of 70 to 90 mm Hg, which suggests th
195 es, the end-diastolic volume at a common end-diastolic pressure on the sequential end-diastolic press
196 , increasing cardiac work while reducing the diastolic pressure, on which coronary flow is dependent.
197 th respect to time but did not change LV end-diastolic pressure or improve LV regional function.
198 function with elevated left ventricular (LV) diastolic pressure or may be merely a manifestation of a
199 tolic pressure without an increase in LV end-diastolic pressure, or decrease in LV dP/dt or LV wall t
200 temperature (P = .31), heart rate (P = .92), diastolic pressure (P = .31), or systolic pressure (P =
201 was seen for stiffness with ventricular end-diastolic pressure (P = 0.001) and pulmonary artery wedg
204 ular pressure by micromanometer provided end-diastolic pressure (P) area (A) relations during initiat
207 f renal-cell cancer (P for trend, <0.001 for diastolic pressure; P for trend, 0.007 for systolic pres
208 n recording of beat-by-beat pulmonary artery diastolic pressure (PAD), stroke volume index (SV index)
211 th SHF and those with DHF; however, elevated diastolic pressures play a pivotal role in the underlyin
215 versely associated with left ventricular end-diastolic pressure (r=-0.728; P<0.001), resulting in a b
216 as SR(E) was significantly related to LV end-diastolic pressure (r=0.52, P=0.005) in the experimental
219 olow-Lyon voltage, in-treatment systolic and diastolic pressure, randomized treatment, and standard c
220 sympathetic response divided by the maximum diastolic pressure reduction during straining, was the s
223 ft ventricular (LV) function measured by end-diastolic pressure response to preload augmentation, con
224 effect on heart rate, LV relaxation, LV end-diastolic pressure, right atrial pressure, or pulmonary
225 section again blunted the increase in LV end-diastolic pressure secondary to volume expansion (+4+/-3
227 ; however, there was no increase in ischemic diastolic pressure, slowing of the calcium transient dec
228 HF, in-treatment differences in systolic and diastolic pressures, Sokolow-Lyon voltage, and Cornell p
229 osis and left atrium diameter (marker of end-diastolic pressure), suggesting an improvement in diasto
230 there was no alteration in left ventricular diastolic pressure, suggesting that ischemic diastolic d
231 elated cardiac dysfunction, including LV end-diastolic pressure, systolic performance, and chamber st
233 e LV contractile function, and higher LV end-diastolic pressure than Ptges(+/+) mice after myocardial
235 proach would mitigate the increase in LV end-diastolic pressure that develops during volume loading i
237 cardiac ischemic events (i.e., the lower the diastolic pressure the greater the risk of coronary hear
238 citation cardiac index, left ventricular end-diastolic pressure, the rate of left ventricular pressur
240 e relations of total and LDL cholesterol and diastolic pressure to distensibility had been present at
241 relaxation and lowering left ventricular end diastolic pressure to facilitate ventricular filling, th
243 mia, cardiac output decreased by 41% and end diastolic pressure tripled for CD36-null hearts, with no
244 omitantly lowered cardiac preload volume and diastolic pressure (venodilation) without a change in ar
246 n fraction, end-systolic volume, and the end-diastolic pressure volume relationship by Ang-(1-9) trea
247 revealed significant improvements in the end-diastolic pressure volume relationship, relaxation kinet
252 oke work relation were measured from the end-diastolic pressure-volume relation before and during del
253 -volume curve and a reduced slope of the end-diastolic pressure-volume relation in the myoblast-trans
256 /leftward shift in the left ventricular (LV) diastolic pressure-volume relationship (P = 0.001), a gr
257 diac hypertrophy, diastolic dysfunction (end diastolic pressure-volume relationship =0.051+/-0.009 in
258 tion, exacerbated diastolic dysfunction (end diastolic pressure-volume relationship =0.11+/-0.004 in
259 d against cardiac diastolic dysfunction (end diastolic pressure-volume relationship =0.110+/-0.009 in
260 n and exacerbated diastolic dysfunction (end diastolic pressure-volume relationship =0.124+/-0.005 in
261 normal dogs underwent measurement of the end-diastolic pressure-volume relationship during caval occl
262 on (p = 0.014) and improvement of the RV end-diastolic pressure-volume relationship in PH pigs treate
265 in left ventricular chamber compliance (end-diastolic pressure-volume relationship; P<0.01) and cont
266 In both models, isolated, perfused heart end-diastolic pressure-volume relationships and passive left
267 d impaired relaxation and upward-shifted end-diastolic pressure-volume relationships despite preserve
268 end-diastolic pressure on the sequential end-diastolic pressure-volume relationships was measured (le
269 ers assessed changes in end-systolic and end-diastolic pressure-volume relationships, and microsphere
273 on hemodynamics over time, mean right atrial diastolic pressure was 9 +/- 0.6 mm Hg with no lean, 10
274 t; 95% CI, 1.04-1.25; P = .006); however, if diastolic pressure was added, model fit improved and the
276 story of revascularization was observed; low diastolic pressure was associated with a relatively lowe
282 In the treated hearts, the increase in end-diastolic pressure was significantly attenuated at the e
284 ction fraction [EF] and left ventricular end-diastolic pressure) was assessed at days 28 and 56.
285 lmonary artery pressure-left ventricular end-diastolic pressure) was normal (<7 mm Hg) or elevated (>
286 dP/dt min (-dP/dt min), and left ventricular diastolic pressure, was measured before inducing VF and
287 ht ventricular mass and left ventricular end diastolic pressure were increased and left ventricular s
288 tricle/body weight, and left ventricular end-diastolic pressure were increased and maximal left ventr
289 index, LV dP/dt40, LV negative dP/dt, and LV diastolic pressure were measured 4 wks after administeri
290 entricle weight/body weight ratio and LV end-diastolic pressure were significantly higher in hearts w
291 ulmonary capillary wedge pressure and LV end-diastolic pressure were significantly increased after th
295 ure and -0.4 (95% CI: -2.9, 2.2) mmHg/kg for diastolic pressure, while in within-pair analysis the va
296 The potential harm of further reducing the diastolic pressure with antihypertensive therapy, especi
297 ericardiotomy blunted the increase in LV end-diastolic pressure with saline infusion, while enhancing
298 c and diastolic pressures, and reductions in diastolic pressure with treatment but greater reductions
300 measurements at 6 months showed lower LV end-diastolic pressures, with enhanced LV function (contract